Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) Consolidated Net Income: 2011-2024

Historic Consolidated Net Income for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $421,000.

  • Mimedx Group's Consolidated Net Income rose 7617.97% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 1464.25%. This contributed to the annual value of $421,000 for FY2024, which is 104.57% up from last year.
  • As of FY2024, Mimedx Group's Consolidated Net Income stood at $421,000, which was up 104.57% from -$9.2 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Consolidated Net Income registered a high of $2.0 million during FY2021, and its lowest value of -$49.3 million during FY2020.
  • For the 3-year period, Mimedx Group's Consolidated Net Income averaged around -$6.3 million, with its median value being -$9.2 million (2023).
  • In the last 5 years, Mimedx Group's Consolidated Net Income slumped by 608.13% in 2022 and then spiked by 104.57% in 2024.
  • Mimedx Group's Consolidated Net Income (Yearly) stood at -$49.3 million in 2020, then soared by 104.09% to $2.0 million in 2021, then crashed by 608.13% to -$10.2 million in 2022, then increased by 10.08% to -$9.2 million in 2023, then soared by 104.57% to $421,000 in 2024.